Hemostemix Inc. (TSXV: HEM) is a biotechnology company occupied with the innovative work and the assembling and commercializing of blood-determined stem cell therapies. Shares outstanding of all classes are 67M, assessing the stocks for 52-weeks are viewed as 0.39 (high) and 0.13 (low).